CAS: 11121-32-7; Mepartricin

该化合物是一种主要用于兽医的抗风素,特别是用于治疗动物真菌感染的抗菌剂,它属于被称为聚乙烯大型硅酸抗生素的化合物类别,其特征是它们能够与真菌细胞膜膜中的消毒素结合,导致渗透性增加,最终导致细胞死亡.麦巴丁显示出广泛的抗风素活动,特别是皮肤植物和一些酵母.它的行动机制涉及破坏对维持细胞功能至关重要的膜完整性.该化合物通常根据所治疗的感染类型进行专题性或系统性管理.就物理特性而言,梅巴丁一般是白色的白粉,在有机溶剂中是可溶的,但水溶性有限.安全性和功效简介在兽医应用中有详细记载,尽管在人类中的使用有限,而且没有广泛研究.与任何抗膜剂一样,抗药性可以发展,需要仔细考虑其在治疗协议中的用途.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-8143035-B2
    优先权日:2006-09-22
    标题 :Pantothenate kinase overexpression and pantothenic acid supplementation in actinomycetes
    发明人:LEE HEI CHAN; SOHNG JAE KYUNG; SAN KA-YIU
    权利人:LEE HEI CHAN; SOHNG JAE KYUNG; SAN KA-YIU; RICE UNIVERSITY
    摘要:The invention relates to the synthesis of polyketides in Actinomycetes by overexpression of pantothenate kinase and supplementation with pantothenic acid. This results in increasing in vivo CoA production and thereby drives increased production of secondary metabolites, such as polyketides.

    专利号:US-9295731-B2
    优先权日:2013-04-01
    标题 :Cleavable drug conjugates, compositions thereof and methods of use
    发明人:NGUYEN MARK QUANG
    权利人:NGUYEN MARK QUANG
    摘要:Base-labile crosslinkers, base-labile conjugates comprising such crosslinkers, methods of their synthesis and use are disclosed.

    专利号:US-7199128-B2
    优先权日:2005-02-02
    标题 :8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
    发明人:BRADBURY BARTON J; WILES JASON ALLAN; DESHPANDE MILIND; WANG QIUPING; HASHIMOTO AKIHIRO; LUCIEN EDLAINE
    权利人:ACHILLION PHARMACEUTICALS INC
    摘要:The invention provides compounds and salts of Formula I and Formula II: n nwhich possess antimicrobial activity. The invention also provides novel synthetic intermediates useful in making compounds of Formula I and Formula II. The variables A 1 , A 8 , R 2 , R 3 , R 5 , R 6 , R 7 , and R 9 are defined herein.n n Certain compounds of Formula I and Formula II disclosed herein are potent and selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula I or Formula II and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula I or Formula II as the only active agent or may contain a combination of compounds of Formula I and/or Formula II and one or more other active agents. The invention also provides methods for treating microbial and protozoal infections in animals.

    专利号:US-2014315720-A1
    优先权日:2012-10-24
    标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
    发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
    权利人:CELANESE ACETATE LLC
    摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Bowen DK, Dielubanza E, Schaeffer AJ. Chronic bacterial prostatitis and chronic pelvic pain syndrome. BMJ Clin Evid. 2015 Aug 27;2015. pii: 1802. Review.
    2: Cohen JM, Fagin AP, Hariton E, Niska JR, Pierce MW, Kuriyama A, Whelan JS, Jackson JL, Dimitrakoff JD. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis. PLoS One. 2012;7(8):e41941. doi: 10.1371/journal.pone.0041941. Epub 2012 Aug 1. Review.
    3: Le B, Schaeffer AJ. Chronic prostatitis. BMJ Clin Evid. 2011 Jul 4;2011. pii: 1802. Review.

    合成参考文献


    摘要:Martini E, Vaggi L, Rucci A, Di Clemente L. [Non surgical treatment of benign prostatic hypertrophy]. J Urol (Paris). 1993;99(6):278–82.
    摘要:Micali F, Giurioli A, Virgili G, Vespasiani G. [Mepartricin as medical treatment of benign prostatic hypertrophy]. J Urol (Paris). 1993;99(6):293–5.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知